BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2025.
World J Clin Cases. Dec 6, 2025; 13(34): 111732
Published online Dec 6, 2025. doi: 10.12998/wjcc.v13.i34.111732
Table 3 Comparison of concentrations of nicotinamide phosphoribosyltransferase and nicotinamide nucleotide adenylyltransferase 1 in low-risk patients with five common pathogenic microorganisms, n (%)

Influenza H1N1 virusLow risk (≤ 90 points)
SARS-CoV-2
Influenza B virus
Streptococcus pneumoniae
Adenovirus
NAMPT (pg/mL) (IQR) 35.33 (35.41) 36.42 (36.43) 35.44 (35.45) 36.17 (38.19) 34.31 (34.39)
NMNAT1 (pg/mL) (IQR) 43.21 (42.95) 45.42 (45.09) 43.15 (42.35) 44.26 (44.41) 42.33 (41.91)


Write to the Help Desk